Point-of-Care (POC) Coagulation Testing Devices Market Trends And Growth Drivers Point To Strong Future Potential
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The point-of-care coagulation testing devices market is experiencing rapid growth, driven by advancements in healthcare diagnostics and an increasing need for efficient blood clotting assessments. As demand rises for quick and reliable testing, this sector is set to expand significantly over the coming years. Below is a detailed breakdown of the market’s size, growth factors, key players, and emerging trends shaping its future.
Steady Market Growth Expected in Point-of-Care Coagulation Testing Devices
The market for point-of-care coagulation testing devices has shown strong expansion recently. It is projected to increase from $2.32 billion in 2025 to $2.55 billion in 2026, registering a compound annual growth rate (CAGR) of 9.7%. This historical growth reflects factors such as a rising incidence of coagulation disorders, broader use of anticoagulant medications, growth in decentralized healthcare models, higher adoption rates of point-of-care diagnostic tools, and technological improvements in coagulation testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
Looking ahead, the market is anticipated to continue this positive trajectory and reach $3.49 billion by 2030, with a CAGR of 8.2% during the forecast period. This future growth is fueled by increasing demand for home-based healthcare diagnostics, a stronger focus on personalized medicine, the proliferation of telehealth-enabled diagnostic platforms, an aging global population, and ongoing innovation in microfluidic testing technologies. Key trends include wider adoption of portable coagulation monitors, a growing preference for rapid point-of-care diagnostic tests, increased utilization of home testing kits, integration of wireless data connectivity in devices, and heightened emphasis on improving test accuracy and reliability.
Factors Propelling the Point-of-Care Coagulation Testing Devices Market
One of the main drivers behind the growth of the point-of-care coagulation testing devices market is the rising prevalence of blood clotting disorders. Such conditions impair the blood’s ability to clot normally, leading to serious health risks. Lifestyle factors like smoking, excessive alcohol intake, and a sedentary way of life contribute to these disorders by damaging blood vessels, altering clotting protein levels, and disrupting blood flow.
Access The Complete Point-of-Care (POC) Coagulation Testing Devices Market Report:
Point-of-care coagulation devices provide healthcare professionals with quick and precise information about a patient’s clotting status, enabling timely adjustments to treatment plans and medication dosages. For example, data from the National Blood Authority in Australia show that in the 2023–2024 period, there were 2,788 individuals diagnosed with hereditary haemophilia A (HMA), an increase from 2,681 patients in the previous year. This steady rise in blood clotting disorders is a key factor supporting market growth.
Product and Application Segments in the Point-of-Care Coagulation Testing Devices Market
The market for point-of-care coagulation testing devices is segmented comprehensively to cover various facets:
1) Product Type: Coagulation Monitors, Consumables, and Coagulation Analyzers
2) Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
3) Method: Prothrombin Time and International Normalized Ratio, Viscoelastic Coagulation Monitoring, and Other Methods
4) Application: Coagulation Testing and Other Applications
5) End-User: Hospitals, Diagnostic Laboratories, Clinics, and Other End-Users
Further subcategories include types of coagulation monitors such as Prothrombin Time (PT) Monitors, International Normalized Ratio (INR) Monitors, Activated Partial Thromboplastin Time (APTT) Monitors, Whole Blood Coagulation Monitors, and Clotting Time Monitors. Consumables cover test strips, reagents, control solutions, calibration kits, lancets, and needles. Coagulation analyzers range from portable and benchtop devices to fully automated and semi-automated analyzers, as well as testing kits designed for home use.
Innovations Shaping the Point-of-Care Coagulation Testing Devices Industry
Leading companies in this market are focusing heavily on the development of immunofluorescence-based quantitative analyzers that enhance the diagnosis and management of coagulation disorders. These analyzers utilize immunofluorescence technology to identify and quantify specific proteins involved in blood clotting, improving diagnostic precision.
For instance, in January 2023, Cipla Limited from India introduced its product Cippoint, an immunofluorescence-based quantitative analyzer. This device delivers rapid test results within 3 to 15 minutes, supporting faster clinical decisions. Its user-friendly design and comprehensive testing capabilities have positioned it as a valuable tool for improving diagnostic workflows and patient outcomes.
Primary Competitors Leading the Point-of-Care Coagulation Testing Devices Market
The market is dominated by several key players, including Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, HemoSonics LLC, Sysmex Corporation, Nihon Kohden Corporation, HORIBA Medical, Helena Laboratories Corporation, Diagnostica Stago, Sekisui Diagnostics, Instrumentation Laboratory, Trinity Biotech plc, CoaguSense Inc., iLine Microsystems, Medirox AB, Hemochron Systems, and Axis-Shield Diagnostics.
Regional Markets Where Demand Is Accelerating Fastest
In 2025, North America held the largest share of the point-of-care coagulation testing devices market. However, demand is quickly growing in other regions covered by the report, such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. These regions collectively contribute to shaping the global outlook for this dynamic market segment.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
